Results 181 to 190 of about 612,801 (299)

Anti-hepatitis C virus threshold value in predicting hepatitis C virus viremia in hemodialysis patients. [PDF]

Rev Assoc Med Bras (1992)
Sarıkaya VA, Ayan U, Aksaray S, Erdinç S, Sarıkaya B, Balık R, Şenbayrak S, Erol S, İnan A, Ceran N.   +9 more
europepmc   +1 more source

Injecting Drug Users' Understanding of Hepatitis C [PDF]

Most Australians who have hepatitis C contracted the virus through the shared use of drug injecting equipment. Further, the prevalence and incidence of hepatitis C virus (HCV) are high among Australian injecting drug users (IDUs), around 50 to 60 percent
Black, E, Day, C, Dolan, K, O'Brien, S, Thetford, Clare   +4 more
core  

Plant-based production of virus-like particles from hepatitis C virus. [PDF]

Planta
López-Castillo LM, Gonzalez-Castro R, Sánchez-Segura L, Aguilar-Barragán BA, Lim MAG.   +4 more
europepmc   +1 more source

Spontaneous dimerization of the hepatitis C virus 3'X RNA. [PDF]

J Biol Chem
Sperstad PD, Holmstrom ED.
europepmc   +1 more source

Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection. [PDF]

World J Gastroenterol
Park J, Jeong JY, Kim SS, Yoon JH, Eun HS, Choi J, Yoon KT, Jung YK, Park SY, Gwak GY, Kim DY, Kim JH, Lee JW, Kim TY, Jang JW, Yu SJ.   +15 more
europepmc   +1 more source

Innate and adaptive immune responses in Hepatitis C virus infections. [PDF]

Virus Res
Kishida Y.
europepmc   +1 more source

A Blind Spot in Post‐Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor‐Related Rejection

Health Care Science, EarlyView.
Björn Nashan
wiley   +1 more source

Hepatitis C Virus Treatment Outcomes Using a Family Medicine Interdisciplinary Team. [PDF]

Ann Fam Med
Hull M.
europepmc   +1 more source

Sjögren's syndrome and hepatitis C virus infection presenting as hypokalemic quadriparesis: A case report. [PDF]

J Int Med Res
Joshi A, Risal UP, Sah NK, Shah B.
europepmc   +1 more source

Correction: MiR-451a attenuates hepatic steatosis and hepatitis C virus replication by targeting glycerol kinase. [PDF]

J Transl Med
Majumdar S, Chowdhury DR, Chakraborty BC, Chowdhury A, Datta S, Banerjee S.   +5 more
europepmc   +1 more source